CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Aurobindo Pharma Ltd.

NSE : AUROPHARMAEQ BSE : 524804 ISIN CODE : INE406A01037Industry : Pharmaceuticals

News

  • Aurobindo Unit Receives VAI Classification from USFDA for Andhra Plant 12 Mar 2026 | 17:13 | Dion Global

    Aurobindo Pharma Limited on Thursday said that its wholly owned subsidiary has received an Establishment Inspection Report (EIR) with a Voluntary Act...more...

  • Aurobindo Pharma - General Updates 12 Mar 2026 | 09:49 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about General Updatesmore...

  • Aurobindo Pharma - Classification Of Unit-IV Of APL Healthcare Limited, A Wholly Owned Subsidiary Of The Company As VAI By Th 12 Mar 2026 | 09:45 | Dion Global

    Intimation of classification of Unit-IV of APL Healthcare Limited a wholly owned subsidiary of the Company as VAI by the US FDA.more...

  • Aurobindo Pharma - Analysts/Institutional Investor Meet/Con. Call Updates 11 Mar 2026 | 13:22 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about Schedule of meetmore...

  • Aurobindo Pharma - Analysts/Institutional Investor Meet/Con. Call Updates 11 Mar 2026 | 13:20 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about Schedule of meetmore...

  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Mar 2026 | 13:15 | Dion Global

    Intimation of plant visit by a group of investors on 17.03.2026.more...

  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Mar 2026 | 13:11 | Dion Global

    Intimation of plant visit by investor group on 16.03.2026.more...

  • Aurobindo Pharma - Analysts/Institutional Investor Meet/Con. Call Updates 09 Mar 2026 | 14:45 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about Schedule of meetmore...

  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 09 Mar 2026 | 14:41 | Dion Global

    Intimation of investor meet to be held on 13.03.2026.more...

  • Eugia Pharma Launches Pomalidomide Capsules in the US Market 04 Mar 2026 | 14:45 | Dion Global

    Eugia Pharma Specialities Limited a wholly owned subsidiary of Aurobindo Pharma Limited has announced the launch of Pomalidomide Capsules in...more...

  • Aurobindo Pharma - Press Release 04 Mar 2026 | 12:14 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 04 2026 titled Eugia Pharma announces launch of Pomalidomide...more...

  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release 04 Mar 2026 | 12:09 | Dion Global

    Submission of press release on launch of Pomalidomide Capsules 1 mg 2 mg 3 mg and 4 mg in the US market by Eugia Pharma Specialities LImited...more...

  • Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 02 Mar 2026 | 12:20 | Dion Global

    Intimation of investor meet.more...

  • Aurobindo Pharma - Analysts/Institutional Investor Meet/Con. Call Updates 02 Mar 2026 | 12:18 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about Schedule of meetmore...

  • Aurobindo Pharma - Clarification On Media Report, 'Aurobindo Pharma'S P Sarath Chandra Reddy Acquitted In Delhi Liquor Scam C 02 Mar 2026 | 09:54 | Dion Global

    Clarification is submitted.more...

  • Aurobindo Pharma - News Verification 02 Mar 2026 | 09:53 | Dion Global

    The Exchange has sought clarification from Aurobindo Pharma Limited with respect to recent news item captioned Aurobindo Pharma s P Sarath C...more...

  • Aurobindo Pharma - News Verification 27 Feb 2026 | 19:17 | Dion Global

    The Exchange has sought clarification from Aurobindo Pharma Limited with respect to recent news item captioned Aurobindo Pharma s P Sarath Chandra Re...more...

  • Aurobindo Pharma - Clarification sought from Aurobindo Pharma Ltd 27 Feb 2026 | 18:17 | Dion Global

    The Exchange has sought clarification from Aurobindo Pharma Ltd with reference to news appeared on https:// www.cnbctv18.com dated February ...more...

  • Aurobindo Pharma - Completion Of US FDA Inspection At Unit I Of Eugia Pharma Specialities Ltd 27 Feb 2026 | 16:16 | Dion Global

    Intimation of completion of USFDA inspection at unit I of Eugia Pharma Specialities Ltdmore...

  • Aurobindo Pharma - General Updates 27 Feb 2026 | 16:10 | Dion Global

    Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Unit I of Eugia Pharma Specialities Ltdmore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex74563.92-1.93%
NSE Index23151.1-2.06%
B500DIVL503456.14-2.58%
BSE 1000 9930.73-2.32%
BSE 100LCTMC8618.83-2.15%
BSE Auto 53876.79-3.27%

Commodity

Gold158013-1.12%
Silver260297-3.09%
Copper1230.5201.74%
Crude Oil884137.86%
Lead19444.35%
Mentha Oil1060.7-0.63%
Nickel1637.3113.50%

Currency

USD/INR 92.26(0.62 %)
GBP/INR 122.91(0.34 %)
EUR/INR 106.59(0.16 %)
JPY/INR 0.58(-0.13 %)
CAD/INR 67.91(0.56 %)
HKD/INR 11.80(0.67 %)